Apollo Commercial Real Estate Finance (ARI) Status update summary
Event summary combining transcript, slides, and related documents.
Status update summary
3 Feb, 2026Transaction overview
Entered a definitive agreement to sell the entire $9 billion commercial real estate loan portfolio to Athene for 99.7% of total loan commitments, net of CECL reserves, excluding two loans expected to be repaid before closing.
Post-transaction, expects approximately $1.4 billion in net cash and a book value per share of about $12.05.
Retains all net equity interests in real estate properties, valued at $466 million as of September 30, 2025.
Transaction approved by the board and a special committee of independent directors; subject to majority stockholder approval.
Includes a 25-day go-shop period to solicit additional offers before finalizing.
Rationale and strategic implications
Sale addresses persistent undervaluation, with shares trading at an average of 0.76–0.77 times book value over the past four years.
Purchase price represents a ~23% premium to recent trading levels and validates book value.
Monetizing the portfolio in a single sale eliminates future asset-level execution risk and provides immediate liquidity.
Intends to maintain REIT status and continue quarterly dividends, targeting an 8% annualized yield post-transaction.
Management will evaluate new commercial real estate strategies and M&A opportunities, leveraging Apollo’s platform.
Future strategy and management alignment
If no new strategy is identified by year-end, will consider all alternatives, including dissolution.
Apollo will reduce its management fee by 50% and take payment in shares during the evaluation period.
Apollo to reimburse up to $10 million in transaction expenses.
Strategic review will consider both internal and external opportunities, including hybrid and equity strategies.
Ongoing evaluation of REO assets for value creation, including lease-up, value-add, and development initiatives.
Latest events from Apollo Commercial Real Estate Finance
- $8.8B loan portfolio, 9.4% yield, and robust Apollo backing drive strong performance.ARI
Investor presentation9 Mar 2026 - Shareholders to vote on $9B asset sale to Athene, revised management fees, and future strategy.ARI
Proxy Filing9 Mar 2026 - Shareholders are asked to approve a $9B commercial loan sale to Athene, offering higher yields.ARI
Proxy Filing20 Feb 2026 - Portfolio sale prompts asset value maximization and strategic review, with shareholder vote pending.ARI
Proxy Filing12 Feb 2026 - 2025 net income was $114M; full loan portfolio sale to Athene at 99.7% of commitments.ARI
Q4 202511 Feb 2026 - Stockholders to vote on $9B asset transfer to Athene, aiming to enhance value and efficiency.ARI
Proxy Filing10 Feb 2026 - Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy.ARI
Proxy Filing6 Feb 2026 - $9B real estate loan portfolio acquired with robust oversight and long-term investment focus.ARI
Proxy Filing6 Feb 2026 - Q2 distributable earnings $0.35/share; $90M CECL reserve expected for healthcare loan.ARI
Q2 20242 Feb 2026